Teachers Advisors’s Crescent Biopharma CBIO Stock Holding History

Teachers Advisors’s Portfolio CBIO Stock Details CBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$946K	Buy	760 +66	+10%	+$75.6K	﹤0.01%	2318
2018 Q4	$657K	Hold	694	–	–	﹤0.01%	2386
2018 Q3	$999K	Buy	694 +51	+8%	+$77.1K	﹤0.01%	2315
2018 Q2	$1.04M	Buy	+643	New	+$1.11M	﹤0.01%	2314
2017 Q2	–	Sell	-144	Closed	-$78K	–	3141
2017 Q1	$78K	Hold	144	–	–	﹤0.01%	3003
2016 Q4	$88K	Hold	144	–	–	﹤0.01%	3023
2016 Q3	$103K	Buy	144 +36	+33%	+$27.5K	﹤0.01%	3001
2016 Q2	$79K	Buy	+108	New	+$74.4K	﹤0.01%	3057
2014 Q2	–	Sell	-148	Closed	-$242K	–	3156
2014 Q1	$242K	Buy	+148	New	+$179K	﹤0.01%	2776

Other funds holding CBIO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Teachers Advisors's CBIO Position: Q1 2019 in Review

Teachers Advisors increased its Crescent Biopharma (CBIO) stake by 9.5% in Q1 2019, buying an estimated $75.6K and bringing the position to 760 shares worth $946K. The position accounts for ﹤0.01% of the portfolio, ranked #2318.

Teachers Advisors first reported a position in CBIO in Q1 2014 and has held it in 9 quarters since. The position peaked at $1.04M in Q2 2018. 77 funds tracked by Wall St. Rank hold CBIO as of Q1 2019.

Teachers Advisors held 760 shares of Crescent Biopharma worth $946K as of Q1 2019.
Teachers Advisors bought 66 Crescent Biopharma shares in Q1 2019, an estimated $75.6K.
Crescent Biopharma made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2318 holding.
Teachers Advisors first reported a position in Crescent Biopharma in Q1 2014 and has held it in 9 quarters since.
Teachers Advisors's Crescent Biopharma position peaked at $1.04M in Q2 2018.
77 funds tracked by Wall St. Rank held Crescent Biopharma as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.